Is dual therapy with raltegravir and protease inhibitors a feasible option in rescue strategy in HIV-1 infection?

Amedeo Ferdinande Capetti; Stefania Piconi; Simona Landonio; Giuliano Rizzardini; Carlo Federico Perno

doi:10.1097/QAI.0b013e31818c7e8e

Is dual therapy with raltegravir and protease inhibitors a feasible option in rescue strategy in HIV-1 infection?

Amedeo Ferdinande Capetti, Stefania Piconi, Simona Landonio, Giuliano Rizzardini, Carlo Federico Perno

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	233-234
Number of pages	2
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	50
Issue number	2
DOIs	https://doi.org/10.1097/QAI.0b013e31818c7e8e
Publication status	Published - Feb 1 2009

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)

Access to Document

10.1097/QAI.0b013e31818c7e8e

Cite this

@article{28b7f693e4ca4f979926e260f26cfe64,

title = "Is dual therapy with raltegravir and protease inhibitors a feasible option in rescue strategy in HIV-1 infection?",

author = "Capetti, {Amedeo Ferdinande} and Stefania Piconi and Simona Landonio and Giuliano Rizzardini and Perno, {Carlo Federico}",

year = "2009",

month = feb,

day = "1",

doi = "10.1097/QAI.0b013e31818c7e8e",

language = "English",

volume = "50",

pages = "233--234",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",